Jirong Lu

2.1k total citations
43 papers, 1.4k citations indexed

About

Jirong Lu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Jirong Lu has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Surgery. Recurrent topics in Jirong Lu's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Protein purification and stability (9 papers) and Glycosylation and Glycoproteins Research (6 papers). Jirong Lu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Protein purification and stability (9 papers) and Glycosylation and Glycoproteins Research (6 papers). Jirong Lu collaborates with scholars based in United States, Singapore and China. Jirong Lu's co-authors include Victor J. Wroblewski, Ying Tang, Lihua Huang, Derrick R. Witcher, Amita Datta‐Mannan, John M. Beals, R.M. Riggin, Chi-Kin Chow, Donmienne Leung and Barrett W. Allan and has published in prestigious journals such as Neuron, PLoS ONE and Analytical Chemistry.

In The Last Decade

Jirong Lu

42 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jirong Lu United States 17 761 656 388 347 115 43 1.4k
Stefan Hamann United States 14 405 0.5× 86 0.1× 217 0.6× 274 0.8× 91 0.8× 26 1.1k
Fei Hua United States 20 679 0.9× 133 0.2× 283 0.7× 171 0.5× 156 1.4× 58 1.4k
Wenying Qin United States 14 942 1.2× 487 0.7× 110 0.3× 128 0.4× 115 1.0× 24 1.9k
Mark Fidock United Kingdom 20 807 1.1× 54 0.1× 358 0.9× 323 0.9× 121 1.1× 32 1.6k
Guy Meno‐Tetang United States 13 419 0.6× 150 0.2× 83 0.2× 218 0.6× 238 2.1× 21 1.2k
Reina N. Fuji United States 13 411 0.5× 265 0.4× 69 0.2× 332 1.0× 286 2.5× 33 1.0k
Hui Xiong China 15 278 0.4× 123 0.2× 108 0.3× 330 1.0× 141 1.2× 51 1.2k
Sonny Khin United States 12 955 1.3× 405 0.6× 95 0.2× 116 0.3× 201 1.7× 24 1.8k
Benbo Gao United States 18 642 0.8× 228 0.3× 157 0.4× 116 0.3× 52 0.5× 33 1.4k
Eric Stefanich United States 23 804 1.1× 410 0.6× 397 1.0× 87 0.3× 236 2.1× 44 1.8k

Countries citing papers authored by Jirong Lu

Since Specialization
Citations

This map shows the geographic impact of Jirong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jirong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jirong Lu more than expected).

Fields of papers citing papers by Jirong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jirong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jirong Lu. The network helps show where Jirong Lu may publish in the future.

Co-authorship network of co-authors of Jirong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jirong Lu. A scholar is included among the top collaborators of Jirong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jirong Lu. Jirong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Datta‐Mannan, Amita, Zhiying Jin, LING LIU, et al.. (2024). Reducing target binding affinity improves the therapeutic index of anti-MET antibody-drug conjugate in tumor bearing animals. PLoS ONE. 19(4). e0293703–e0293703. 11 indexed citations
2.
Goh, Benjamin, Jirong Lu, Lata Raman, et al.. (2023). Choosing the larger kidney on CT volumetry: a study on the early post-donation kidney function of living donors. International Urology and Nephrology. 56(1). 97–102.
3.
So, Wei Zheng, et al.. (2022). An in vitro Comparative Assessment of Single-Use Flexible Ureteroscopes Using a Standardized Ureteroscopy Training Model. Urologia Internationalis. 106(12). 1279–1286. 7 indexed citations
4.
Wen, Yi, Xiaoli Wang, Jill A. Willency, et al.. (2020). Post-hoc assessment of the immunogenicity of three antibodies reveals distinct immune stimulatory mechanisms. mAbs. 12(1). 1764829–1764829. 32 indexed citations
5.
Ong, Chloe Shu Hui, et al.. (2020). Implementation of a Ureteric Colic Telemedicine Service: A Mixed Methods Quality Improvement Study. Urology. 147. 14–20. 7 indexed citations
6.
Benschop, Robert J., Chi-Kin Chow, Yu Tian, et al.. (2019). Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. mAbs. 11(6). 1175–1190. 34 indexed citations
7.
Lu, Jirong, et al.. (2019). Validation of laparoscopy and flexible ureteroscopy tasks in inanimate simulation training models at a large-scale conference setting. Asian journal of urology. 8(2). 215–219. 1 indexed citations
8.
Liu, Ling, Kristine Kikly, Jirong Lu, et al.. (2016). Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A. Journal of Inflammation Research. 9. 39–39. 172 indexed citations
9.
Lu, Jirong, et al.. (2015). Training improves laparoscopic tasks performance and decreases operator workload. Surgical Endoscopy. 30(5). 1742–1746. 29 indexed citations
10.
Datta‐Mannan, Amita, Donmienne Leung, Ying Tang, et al.. (2015). Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics. mAbs. 7(3). 483–493. 114 indexed citations
11.
Xu, Dan, Zhimin Chen, Shunying Zhao, et al.. (2015). Application of Clinico-Radiologic-Pathologic Diagnosis of Diffuse Parenchymal Lung Diseases in Children in China. PLoS ONE. 10(1). e0116930–e0116930. 1 indexed citations
12.
Smith, Rosamund C., Linda M. O’Bryan, Pamela J. Mitchell, et al.. (2015). Increased brain bio-distribution and chemical stability and decreased immunogenicity of an engineered variant of GDNF. Experimental Neurology. 267. 165–176. 13 indexed citations
13.
Datta‐Mannan, Amita, Jirong Lu, Derrick R. Witcher, et al.. (2015). The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies. mAbs. 7(6). 1084–1093. 65 indexed citations
14.
Hansen, Ryan J., Robin M. Brown, Jirong Lu, & Victor J. Wroblewski. (2013). Qualification of a free ligand assay in the presence of anti-ligand antibody Fab fragments. mAbs. 5(2). 288–296. 12 indexed citations
15.
DeMattos, Ronald B., Jirong Lu, Ying Tang, et al.. (2012). A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice. Neuron. 76(5). 908–920. 276 indexed citations
16.
Datta‐Mannan, Amita, Derrick R. Witcher, Jirong Lu, & Victor J. Wroblewski. (2012). Influence of improved FcRn binding on the subcutaneous bioavailability of monoclonal antibodies in cynomolgus monkeys. mAbs. 4(2). 267–273. 43 indexed citations
17.
Yan, Liang, Kirk W. Johnson, Emily C. Rothstein, et al.. (2011). Discovery of potent, cyclic calcitonin gene‐related peptide receptor antagonists. Journal of Peptide Science. 17(5). 383–386. 11 indexed citations
18.
Wang, Guilan & Jirong Lu. (2010). Retrovirus-mediated delivery of an IL-4 receptor antagonist inhibits allergic responses in a murine model of asthma. Science China Life Sciences. 53(10). 1215–1220. 2 indexed citations
19.
Xia, Xianzhu, et al.. (2006). Roles of ICAM-1 and it's Receptors in HPAIV Pneumonia. Virologica Sinica. 21(1). 38–42. 1 indexed citations
20.
Li, Liu, et al.. (2005). Survey analysis of 0-14 years old children with asthma in Changchun city. Journal of Jilin University. 31(1). 149–151. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Hamann Breakdown of academic impact, for papers by Fei Hua Breakdown of academic impact, for papers by Wenying Qin Breakdown of academic impact, for papers by Mark Fidock Breakdown of academic impact, for papers by Guy Meno‐Tetang Breakdown of academic impact, for papers by Reina N. Fuji Breakdown of academic impact, for papers by Hui Xiong Breakdown of academic impact, for papers by Sonny Khin Breakdown of academic impact, for papers by Benbo Gao Breakdown of academic impact, for papers by Eric Stefanich
Rankless by CCL
2026